FDA Approves New Imaging Drug to Help Identify Ovarian Cancer Lesions
WASHINGTON, D.C. — The U.S. Food and Drug Administration this week approved Cytalux (pafolacianine), an imaging drug intended to assist surgeons in identifying ovarian cancer lesions. The drug is designed …
FDA Approves New Imaging Drug to Help Identify Ovarian Cancer Lesions Read More